Suchergebnisse - "Song, Yong-Ping"

PubPharm (74)

1

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia : a randomized phase 3 trial with 5-year outcomes

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tian, J. | Song, Y. | Zhang, G. | +24

2

Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tian, J. | Song, Y. | Zhang, G. | +24

3

A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning : a nationwide prospective cohort study

enthalten in: Science bulletin | 2023

von An, Z. | Wu, Y. | Hou, Y. | +65

4

Orelabrutinib for the treatment of relapsed or refractory MCL : a phase 1/2, open-label, multicenter, single-arm study

enthalten in: Blood advances | 2023

von Deng, L. | Zhou, K. | Liu, L. | +26

5

Efficacy of Tyrosine Kinase Inhibitor Combined with Decitabine, Homoharringtonine, Interferon in the Maintenance Therapy of Blast Phase Chronic Myeloid Leukemia

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2023

von Li, Z. | Zhao, H. | Zhang, Y. | +1

6

Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic : A Report From the Chinese Blood and Marrow Transplantation Registry Group

enthalten in: Transplantation and cellular therapy | 2023

von Xu, L. | Lu, D. | Wu, D. | +21

7

Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenström's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study

enthalten in: EClinicalMedicine | 2022

von Cao, X. | Jin, J. | Fu, C. | +17

8

Bioinformatics Analysis of Microarray Data in Myelodysplastic Syndrome Based on Gene Expression Omnibus Database

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2022

von Ding, B. | Zhou, H. | Liu, L. | +3

9

Hematopoietic stem cell transplantation activity in China 2019 : a report from the Chinese Blood and Marrow Transplantation Registry Group

enthalten in: Bone marrow transplantation | 2021

von Xu, L. | Lu, P. | Wu, D. | +17

10

Single VHH-directed BCMA CAR-T cells cause remission of relapsed/refractory multiple myeloma

enthalten in: Leukemia | 2021

von Han, L. | Zhang, J. | Zhou, J. | +14

1
2
3
4
5
6
7
8
Nächster »
[8]